T1	Participants 1 25	Metastatic breast cancer
T2	Participants 158 289	Seventy-nine patients with an histologically proven disseminated breast cancer, never treated before with additive hormonal therapy
T3	Participants 793 804	30 patients
T4	Participants 824 835	23 patients
